• el
  • en


Among the strategic goals that Medical Pharmaquality have set, is the development of successful cooperation with other pharmaceutical companies in Greece and abroad.

Medical Pharmaquality was founded in March 2011. It is a fast growing company (with a growth rate of 100% in values) in the Greek market. The company has already created new cooperation with the following companies:

  • With Italian company Riverfarma for the exclusive promotion of Nevralip 600mg retard in the Greece.
  • With Greek company Rafarm for the promotion of Leruze & Umolit in the Greek market.
  • With Ogechi Health for the export of MPQs product in Kossovo.
Ogechi Health